235 related articles for article (PubMed ID: 32912389)
1. Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19.
Pranata R; Soeroto AY; Huang I; Lim MA; Santoso P; Permana H; Lukito AA
Int J Tuberc Lung Dis; 2020 Aug; 24(8):838-843. PubMed ID: 32912389
[No Abstract] [Full Text] [Related]
2. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression.
Pranata R; Huang I; Lim MA; Wahjoepramono EJ; July J
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104949. PubMed ID: 32927523
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.
Alqahtani JS; Oyelade T; Aldhahir AM; Alghamdi SM; Almehmadi M; Alqahtani AS; Quaderi S; Mandal S; Hurst JR
PLoS One; 2020; 15(5):e0233147. PubMed ID: 32392262
[TBL] [Abstract][Full Text] [Related]
4. Smoking, ACE-2 and COVID-19: ongoing controversies.
Leung JM; Sin DD
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430431
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
He Y; Xie M; Zhao J; Liu X
Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
[TBL] [Abstract][Full Text] [Related]
6. Current smoking is not associated with COVID-19.
Rossato M; Russo L; Mazzocut S; Di Vincenzo A; Fioretto P; Vettor R
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32350106
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and smoking: is nicotine the hidden link?
Russo P; Bonassi S; Giacconi R; Malavolta M; Tomino C; Maggi F
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32341101
[TBL] [Abstract][Full Text] [Related]
8. Is chronic obstructive pulmonary disease an independent predictor for adverse outcomes in coronavirus disease 2019 patients?
Xiao WW; Xu J; Shi L; Wang YD; Yang HY
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11421-11427. PubMed ID: 33215464
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I
PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
McAlinden KD; Eapen MS; Lu W; Chia C; Haug G; Sohal SS
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430427
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis.
Fang X; Li S; Yu H; Wang P; Zhang Y; Chen Z; Li Y; Cheng L; Li W; Jia H; Ma X
Aging (Albany NY); 2020 Jul; 12(13):12493-12503. PubMed ID: 32658868
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
[TBL] [Abstract][Full Text] [Related]
13. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression.
Pranata R; Lim MA; Huang I; Raharjo SB; Lukito AA
J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926899. PubMed ID: 32408793
[TBL] [Abstract][Full Text] [Related]
14. [Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2020 May; 43(5):421-426. PubMed ID: 32153171
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis.
Gülsen A; Yigitbas BA; Uslu B; Drömann D; Kilinc O
Pulm Med; 2020; 2020():7590207. PubMed ID: 32963831
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and the nicotinic cholinergic system.
Farsalinos K; Angelopoulou A; Alexandris N; Poulas K
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32444400
[TBL] [Abstract][Full Text] [Related]
17. Identifying Patients at Greatest Risk of Mortality due to COVID-19: A New England Perspective.
Smith AA; Fridling J; Ibrahim D; Porter PS
West J Emerg Med; 2020 Jul; 21(4):785-789. PubMed ID: 32726242
[TBL] [Abstract][Full Text] [Related]
18. [Asthma and COPD management during the COVID-19 pandemic].
Daccord C; Touilloux B; Von Garnier C
Rev Med Suisse; 2020 May; 16(692):933-938. PubMed ID: 32374540
[TBL] [Abstract][Full Text] [Related]
19. Covid-19 and COPD: A Personal Reflection.
Russell R
Int J Chron Obstruct Pulmon Dis; 2020; 15():883-884. PubMed ID: 32425514
[No Abstract] [Full Text] [Related]
20. COVID-19 Susceptibility in chronic obstructive pulmonary disease.
Olloquequi J
Eur J Clin Invest; 2020 Oct; 50(10):e13382. PubMed ID: 32780415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
